ACCELERATE DIAGNOSTICS INC's ticker is and the CUSIP is 00430HAB8. A total of 15 filers reported holding ACCELERATE DIAGNOSTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2,835,000 | +3.5% | 3,000,000 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $2,738,000 | +38.9% | 3,000,000 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $1,971,000 | -7.6% | 3,000,000 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $2,134,000 | -1.2% | 3,000,000 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $2,160,000 | +4.8% | 3,000,000 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $2,062,000 | +0.1% | 3,000,000 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $2,059,000 | +1.1% | 3,000,000 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $2,036,000 | +18.3% | 3,000,000 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $1,721,000 | -11.9% | 3,000,000 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $1,954,000 | -10.5% | 3,000,000 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $2,183,000 | +30.4% | 3,000,000 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $1,674,000 | -26.1% | 3,000,000 | 0.0% | 0.00% | -33.3% |
Q4 2019 | $2,265,000 | -9.9% | 3,000,000 | 0.0% | 0.00% | -25.0% |
Q3 2019 | $2,514,000 | -6.3% | 3,000,000 | 0.0% | 0.00% | -20.0% |
Q2 2019 | $2,684,000 | – | 3,000,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cowen Prime Advisors LLC | 7,580,000 | $5,330,000 | 1.98% |
Samjo Capital LLC | 2,600,000 | $1,828,000 | 1.34% |
PenderFund Capital Management Ltd. | 5,560,000 | $5,031,000 | 1.32% |
Indaba Capital Management, L.P. | 11,000,000 | $7,698,000 | 0.82% |
Saltoro Capital, LP | 900,000 | $642,000 | 0.23% |
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 8,000,000 | $5,625,000 | 0.08% |
WOLVERINE ASSET MANAGEMENT LLC | 4,000,000 | $2,814,000 | 0.02% |
INGALLS & SNYDER LLC | 815,000 | $532,000 | 0.02% |
BlueCrest Capital Management Ltd | 1,000,000 | $662,000 | 0.02% |
Citadel Advisors | 65,655,000 | $46,617,000 | 0.01% |